Division of Gastroenterology, Department of Internal Medicine, Kralovske Vinohrady University Hospital, Prague, Czech Republic.
The Third Faculty of Medicine, Charles University, Prague, Czech Republic.
J Clin Lab Anal. 2024 Oct;38(19-20):e25105. doi: 10.1002/jcla.25105. Epub 2024 Oct 3.
Faecal microbiota transplantation (FMT) is a developing therapy for disorders related to gut dysbiosis. Despite its growing application, standardised protocols for FMT filtrate preparation and quality assessment remain undeveloped. The viability of bacteria in the filtrate is crucial for FMT's efficacy and for validating protocol execution. We compared two methods-in vitro cultivation and membrane integrity assessment-for their accuracy, reproducibility and clinical applicability in measuring bacterial viability in frozen FMT stool filtrate.
Bacterial viability in stool filtrate was evaluated using (i) membrane integrity through fluorescent DNA staining with SYTO9 and propidium iodide, followed by flow cytometry and (ii) culturable bacteria counts (colony-forming units, CFU) under aerobic or anaerobic conditions.
Using different types of samples (pure bacterial culture, stool of germ-free and conventionally bred mice, native and heat-treated human stool), we refined the bacterial DNA staining protocol integrated with flow cytometry for assessment of bacterial viability in frozen human stool samples. Both the membrane integrity-based and cultivation-based methods exhibited significant variability in bacterial viability across different FMT filtrates, without correlation. The cultivation-based method showed a mean coefficient of variance of 30.3%, ranging from 7.4% to 60.1%. Conversely, the membrane integrity approach yielded more reproducible results, with a mean coefficient of variance for viable cells of 6.4% ranging from 0.2% to 18.2%.
Bacterial viability assessment in stool filtrate using the membrane integrity method offers robust and precise data, making it a suitable option for faecal material evaluation in FMT. In contrast, the cultivation-dependent methods produce inconsistent outcomes.
粪便微生物群移植(FMT)是一种治疗与肠道菌群失调相关疾病的新兴疗法。尽管其应用不断增加,但 FMT 滤液制备和质量评估的标准化方案仍未得到开发。滤液中细菌的活力对于 FMT 的疗效和验证方案的执行至关重要。我们比较了两种方法——体外培养和膜完整性评估——在测量冷冻 FMT 粪便滤液中细菌活力的准确性、重现性和临床适用性。
使用(i)通过荧光 DNA 染色与 SYTO9 和碘化丙啶结合评估膜完整性,然后进行流式细胞术和(ii)在需氧或厌氧条件下培养可培养细菌计数(菌落形成单位,CFU)来评估粪便滤液中的细菌活力。
使用不同类型的样本(纯细菌培养物、无菌和常规饲养小鼠的粪便、天然和热处理的人粪便),我们改进了与流式细胞术结合用于评估冷冻人粪便样本中细菌活力的细菌 DNA 染色方案。基于膜完整性和基于培养的方法在不同 FMT 滤液中的细菌活力都表现出显著的变异性,没有相关性。基于培养的方法显示出 30.3%的平均变异系数,范围为 7.4%至 60.1%。相比之下,膜完整性方法产生了更具重现性的结果,活细胞的平均变异系数为 6.4%,范围为 0.2%至 18.2%。
使用膜完整性方法评估粪便滤液中的细菌活力提供了稳健和精确的数据,使其成为 FMT 中粪便材料评估的合适选择。相比之下,依赖培养的方法产生了不一致的结果。